Cholamandalam Financial Holdings is a core investment company holding 43.74% of NBFC Cholamandalam Investment and Finance Company and 60% of Cholamandalam MS General Insurance, and its Q2 FY 2026-2027 print arrives with lending momentum strong but the insurance arm under pressure. The key things the results will speak to are whether CIFCL holds its 22-23% AUM growth guidance with NIM up 42 bps YoY, and whether Chola MS shows the first checkpoint of its motor OD loss-ratio glide path from over 80% toward the high-70s.
| Results date | November 06, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 11,214 Cr |
| Previous quarter PAT | Rs. 1,789 Cr |
| Market cap | Rs. 25,805.51 Cr |
| CMP | Rs. 1,374.8 |
The board meets on November 6, 2026 to consider the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026 (Q2/H1 FY27). The trading window remained closed from October 1 to November 8, 2026.
A DAM Capital Advisors group call is scheduled for November 6, 2026 at 4:00 p.m. IST, per the company's investor-relations announcement of October 15, 2026.
The Q2 FY27 print tests two diverging trajectories: CIFCL's lending momentum, which ran at 23% AUM growth and 22% disbursement growth in Q1 with NIM up 42 bps YoY and ROA at 3.7%, and Chola MS's insurance turnaround, where motor OD loss ratios crossed 80% in Q1 against a management glide path to the high-70s within a couple of quarters.
The demand backdrop through July-September was supportive — FADA reported the best-ever July vehicle retails with CV up 24.04% and tractors up 28.10%, and NBFC sector credit grew 14.9% YoY in July with NBFC retail loans accelerating to 21.4% — though tractors softened to just 0.84% growth in August on a monsoon deficient at 85% of LPA as of September 14.
On funding costs, the quarter itself was largely insulated, with the 25 bps repo hike to 5.50% landing only on October 7 after the window closed, consistent with management's guide of roughly a 10 bps cost-of-funds increase in H2 FY27, though G-sec yields hardened to 6.95% at end-August from 6.74% at end-June.
For Chola MS, the September 23, 2026 IRDAI consultation paper proposing a cut in the Expenses of Management limit from 30% of GWP to 20% within five years, alongside the pending motor TP Supreme Court matter, adds regulatory and litigation overhangs management is likely to be asked about. The call should also carry the preliminary IFRS profitability and ROE impact observations management promised by this quarter, ahead of IFRS taking effect April 1, 2027.
CIFCL growth vs FY27 guidance: Q1 ran ahead of the full-year guide on both AUM and disbursements.
Chola MS motor OD loss ratio and ROE path: Q2 is the first checkpoint on the insurance corrective actions.
Cost of funds and asset quality: Funding costs hardened through the quarter even as the repo hike came after it.
IFRS readiness and strategic updates: Several dated milestones fall due around this call.
Management attributed the gap to motor OD loss ratios rising 8%-9% for Chola MS versus 6%-7% for the industry, along with conservative third-party provisioning that is 12% higher than peers. Improvement is expected via the Expenses of Management glide path and crop business re-entry.
CFO Arul Selvan stated the company is 'targeting overall AUM growth in the range of 20% to 23%' for FY27, reiterated in Q1 as 'still holding to the 22-23% growth guidance'. Q1 FY27 AUM grew 23% to Rs. 2,54,392 Cr.
Management characterized the Rs. 200 Cr overlay as a precautionary buffer against global uncertainties and said no additional credit overlays were required at this stage. Q1 FY27 net credit cost was 1.5% versus 1.8% last year.
Management pointed to SBPL pre-tax ROA of 7.9%, net credit losses of 2.3%, and Stage 3 recognition that depends on the ARC given small ticket sizes, while expressing confidence in over 30% disbursement growth. At Q3 FY26 they called the quarter's net credit cost a peak, with stabilization expected by Q4-end/Q1.
Q1 FY27 consolidated total income was Rs. 11,214 Cr, up 20% YoY, and PAT was Rs. 1,789 Cr, up 42% YoY, with EPS of Rs. 42.92 versus Rs. 30.81. Profit attributable to owners rose 39.32% YoY to Rs. 805.96 Cr, with non-controlling interests taking 54.92% of consolidated PAT.
Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.